Lobbying Information
Subject Matters
- Government Procurement
- Health
- Research and Development
Subject Matter Details
Grant, Contribution or Other Financial Benefit
- Financial support (in the form of subsidy or grant) for the development and manufacturing of a vaccine for COVID-19. This financial assistance would be used for the preparation for clinical studies, the purchase of equipment from suppliers, and the progress of the authorization process with the regulatory authorities. Details as to the nature and dollar amount of any financial assistance that may be granted are unknown.
Legislative Proposal, Bill or Resolution
- Monitoring and engaging on the Act respecting certain measures in response to COVID-19 and the changes to the Patent Act, including eventual regulations and guidelines, formally known as Bill C-13, An Act respecting certain measures in response to COVID-19
Policies or Program
- COVID-19: Regarding the development of a COVID-19 vaccine & policies and related to the COVID-19 pandemic.
- Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages and discussion on COVID19 potential impacts
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Health Canada (HC)
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
National Research Council (NRC)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Health Agency of Canada (PHAC)
-
Public Services and Procurement Canada (PSPC)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
25 Davids Drive
Hauppauge, NY 11788
United States of America
Telephone number:
206-612-5252
Web address:
https://www.covaxx.com/
Client representative
Mei Mei Hu Hu, Chief Executive Officer
Parent Company Information
COVAXX LLC is not a subsidiary of any other parent companies.
Coalition Members Information
COVAXX LLC is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of COVAXX LLC are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
COVAXX LLC does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Regan Watts
|
Designated public offices held
Business address:
254 Sutherland Drive
Toronto, ON M4G 1J3
Canada
Telephone number:
416-528-2901
Consultant Firm and Address
Firm:
Fratton Park Inc. / Fratton Park Inc.
Address:
254 Sutherland Drive
Toronto, ON M4G 1J3
Canada
Telephone number:
416-528-2901